Request Demo
Last update 21 Nov 2024
β-globin restored autologous hematopoietic stem cells (Hemogen Gene)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type CRISPR/Cas9 |
Synonyms β-globin restored autologous hematopoietic stem cells(Shenzhen Hemogen), 编码T87Q倍他珠蛋白慢病毒转导的自体造血干祖细胞（禾沐基因） + [2] |
Target |
Mechanism β-globin modulators(Hemoglobin beta chain modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
6
Clinical Trials associated with β-globin restored autologous hematopoietic stem cells (Hemogen Gene)TCTR20241029003
An Open Label Study Evaluating the Safety and Efficacy of HGI-001 Injection in Patients with Transfusion-Dependent Beta-Thalassemia
TCTR20240910004
A Pilot Clinical Study Evaluating the Safety and Efficacy of HGI-001 Injection in Patients with Transfusion-Dependent Beta-Thalassemia
NCT06655662
An Open, Multi-center, Phase I Clinical Study on the Safety and Efficacy of HGI-001 Injection in Patients with Transfusion-Dependent Β-Thalassemia.
100 Clinical Results associated with β-globin restored autologous hematopoietic stem cells (Hemogen Gene)
Login to view more data
100 Translational Medicine associated with β-globin restored autologous hematopoietic stem cells (Hemogen Gene)
Login to view more data
100 Patents (Medical) associated with β-globin restored autologous hematopoietic stem cells (Hemogen Gene)
Login to view more data
100 Deals associated with β-globin restored autologous hematopoietic stem cells (Hemogen Gene)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Transfusion-dependent Beta Thalassemia | Phase 2 | - | - | |
| Beta-Thalassemia | Phase 1 | CN | 12 Jun 2024 | |
| Transfusion-dependent Thalassemia | Phase 1 | CN | 12 Jun 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free